Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 1/20 | 0.51 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.51 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.49 |
| ▸ | ACKR3 | P25106 | 4/20 | 0.48 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.48 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 4/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.46 |
| ▸ | DRD3 | P35462 | 3/20 | 0.46 |
| ▸ | DRD2 | P14416 | 2/20 | 0.46 |
| ▸ | HTR2B | P41595 | 2/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | STAT6 | P42226 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30977656 | 1.00 | HSD17B1 (0.51) | HSD17B1HSD17B2CHEK1ACKR3TMEM97 | |
| Hydrochloric Acid SCHEMBL30977641 | 0.99 | HSD17B1 (0.50) | HSD17B1HSD17B2CHEK1ACKR3TMEM97 | |
| Hydrochloric Acid SCHEMBL21625739 | 0.99 | HSD17B1 (0.50) | HSD17B1HSD17B2CHEK1ACKR3TMEM97 | |
| SCHEMBL21625732 | 0.89 | HSD17B1 (0.53) | HSD17B1HSD17B2CHEK1ACKR3HTR2C | |
| SCHEMBL30977651 | 0.89 | HSD17B1 (0.53) | HSD17B1HSD17B2CHEK1ACKR3HTR2C | |
| Hydrochloric Acid SCHEMBL21625719 | 0.88 | HSD17B1 (0.52) | HSD17B1HSD17B2CHEK1ACKR3 | |
| Hydrochloric Acid SCHEMBL30977644 | 0.88 | HSD17B1 (0.52) | HSD17B1HSD17B2CHEK1ACKR3 | |
| SCHEMBL21625717 | 0.87 | MCHR1 (0.51) | ACKR3TMEM97SIGMAR1LMNAADRA2A | |
| SCHEMBL21625714 | 0.86 | HSD17B1 (0.50) | HSD17B1HSD17B2ACKR3LMNAALDH1A1 | |
| SCHEMBL30977647 | 0.86 | HSD17B1 (0.50) | HSD17B1HSD17B2ACKR3LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3814340-B1 | NOVEL CATECHOL DERIVATIVES OR SALT THEREOF, PROCESSES FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | HEXAPHARMATEC CO LTD (KR) | 2024-12-18 | — | — | EP | disclosed |
| US-12110281-B2 | Catechol derivatives or salt thereof, processes for preparing the same, and pharmaceutical compositions comprising the same | HEXAPHARMATEC CO., LTD. (KR) | 2024-10-08 | — | — | US | disclosed |
| CN-112437773-B | Catechol derivatives or salts thereof, process for preparing the same and pharmaceutical compositions containing the same | 六合医药科技有限公司 | 2024-06-11 | — | — | CN | disclosed |
| US-20210340119-A1 | NOVEL CATECHOL DERIVATIVES OR SALT THEREOF, PROCESSES FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | HEXAPHARMATEC CO., LTD. (KR) | 2021-11-04 | — | — | US | disclosed |
| US-20210340119-A1 | NOVEL CATECHOL DERIVATIVES OR SALT THEREOF, PROCESSES FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | HEXAPHARMATEC CO., LTD. (KR) | 2021-11-04 | — | — | US | disclosed |
| EP-3814340-A1 | NOVEL CATECHOL DERIVATIVES OR SALT THEREOF, PROCESSES FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | Hexapharmatec Co., Ltd. (KR) | 2021-05-05 | — | — | EP | disclosed |
| CN-112437773-A | Novel catechol derivative or salt thereof, method for producing the same, and pharmaceutical composition containing the same | 六合医药科技有限公司 | 2021-03-02 | — | — | CN | disclosed |
| WO-2020017878-A1 | NOVEL CATECHOL DERIVATIVES OR SALT THEREOF, PROCESSES FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | HEXAPHARMATEC CO., LTD. (KR) | 2020-01-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12110281-B2 | Catechol derivatives or salt thereof, processes for preparing the same, and pharmaceutical compositions comprising the same | COMT, TYR, REN | HSD17B1 1028/4885HSD17B2 744/4885CHEK1 3870/4885 |
| US-20210340119-A1 | NOVEL CATECHOL DERIVATIVES OR SALT THEREOF, PROCESSES FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | COMT, TYR, REN | HSD17B1 1260/4885HSD17B2 911/4885CHEK1 3815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.